A detailed history of Boomfish Wealth Group, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Boomfish Wealth Group, LLC holds 34,997 shares of ESPR stock, worth $84,342. This represents 0.04% of its overall portfolio holdings.

Number of Shares
34,997
Previous 29,895 17.07%
Holding current value
$84,342
Previous $66.4 Million 12.99%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$1.61 - $2.73 $8,214 - $13,928
5,102 Added 17.07%
34,997 $57.7 Million
Q1 2024

May 03, 2024

BUY
$2.02 - $3.02 $60,387 - $90,282
29,895 New
29,895 $80.1 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Boomfish Wealth Group, LLC Portfolio

Follow Boomfish Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boomfish Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boomfish Wealth Group, LLC with notifications on news.